Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of August 7, 2025 • 11:01 PM ET

Date/Time Source News Release
07/31/2025 09:25 AM EDT PR Newswire Acurx Pharmaceuticals, Inc. Announces Reverse Stock Split
07/24/2025 07:01 AM EDT PR Newswire Acurx Pharmaceuticals to Discuss Second Quarter 2025 Financial Results on August 12, 2025 Conference Call and Provide Business Update
06/18/2025 08:00 PM EDT PR Newswire /C O R R E C T I O N -- Acurx Pharmaceuticals, Inc./
06/17/2025 09:47 PM EDT PR Newswire Acurx Pharmaceuticals, Inc. Announces Exercise of Warrants for $2.67 Million Gross Proceeds
06/17/2025 07:01 AM EDT PR Newswire Acurx Announces Publication in Lancet Microbe of Phase 2b Clinical Trial Data for Ibezapolstat in CDI
06/09/2025 07:30 AM EDT PR Newswire Acurx Pharmaceuticals Announces Presentation of Results from Leiden University Medical Center Public-Private Partnership for Its DNA pol IIIC Inhibitors at the Federation of American Societies for Experimental Biology Scientific Conference
05/13/2025 07:01 AM EDT PR Newswire Acurx Pharmaceuticals, Inc. Reports First Quarter Results and Provides Business Update
04/30/2025 07:30 AM EDT PR Newswire Acurx Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 13, 2025 Conference Call and Provide Business Update
04/28/2025 07:30 AM EDT PR Newswire Acurx Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
04/17/2025 07:30 AM EDT PR Newswire Indian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors
Page

Additional News

As of August 7, 2025 • 11:01 PM ET

Date/Time Source News Release
07/09/2025 05:45 PM EDT SeekingAlpha Acurx Pharmaceuticals files $50M mixed shelf offering
06/18/2025 09:40 AM EDT Zacks Are Medical Stocks Lagging Acurx Pharmaceuticals (ACXP) This Year?
06/17/2025 07:37 AM EDT 24/7 Market News Acurx Publishes Promising Phase 2b CDI Trial Data for Ibezapolstat in Lancet Microbe
05/21/2025 04:37 PM EDT SeekingAlpha Acurx files to sell 10.9M shares of common stock for holders
05/13/2025 02:00 PM EDT SeekingAlpha Acurx signals progress in Phase 3 ibezapolstat program with $12M credit line following regulatory alignment
05/13/2025 01:59 PM EDT SeekingAlpha Acurx Pharmaceuticals, Inc. (ACXP) Q1 2025 Earnings Call Transcript
05/13/2025 08:07 AM EDT SeekingAlpha Acurx Pharmaceuticals GAAP EPS of -$0.11
05/13/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, May 13th, 2025
05/13/2025 05:30 AM EDT US Earnings Reports Expected earnings - Acurx Pharmaceuticals Inc.
05/07/2025 12:42 PM EDT Zacks Waters Q1 Earnings Surpass Estimates, Revenue Rise Y/Y
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.